# Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-30 16:29 UTC · Category: Business · Sources: 3 · Current Velocity: 1.3

## Key People, Organizations & Locations
Lilly, Eli

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| yahoo.com | Emerging drug helps some patients lose up to quarter of body weight | 2026-09-30 14:15 | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxQNHFzaDBpY2tUTzhBQTBWb0VlcW05dnlwbXROX2VuYUxIQl9CRGxHTDVkcEJlNmZUWnAzaS1EZnFWRzk3MnZqRFhhS1B4TmZ0QkxRQmZpaXp4TU56RWRWeXJ3YnI2MG9vVzVYeXgyN2xpdUN3SE5PcjVaak4wTm9aR3dtenpjUTdwcFFvVmlueVFhSVd5T0NN?oc=5) |
| USA Today | Lilly's retatrutide GLP-1 delivers average weight loss of 50 pounds | 2026-09-30 14:15 | [Source Link](https://news.google.com/rss/articles/CBMixwFBVV95cUxPNjNud0VKWlRCbm5iWDRLLWU3UDRjbmNrWjJ6SG5VZ0QtRUFYUGhvUnJXaHdaeFQ5bXhKcVlxUjNWU3NBT3MydlBQWEJNLXRyUkpfQkZfa0hQb25wbEVSTjBOQUp3QVN2dDhyWU1kUFRFS1hLRjlyaVNvNkRSdk9VNkZtNG94bWN1QUxCN0Z0N2ktMUJ1WXlLQ3RZWWdRRjRtZUFRN19HU2RQTUN0TWo5MjJ2b1djTktHeUttbE1qN01yS0pLeW44?oc=5) |
| Fierce Biotech | Lilly raises diabetes weight loss bar with amylin-Zepbound combo | 2026-09-30 14:15 | [Source Link](https://news.google.com/rss/articles/CBMilwFBVV95cUxNbVhpMnNWLXNzdXlmT2dzLXE3Ul91aDlTbmg3bFBSRk5TX29VRFlvMjBac1dLWDBUb0c2dWRLaDdCLXoyM1BaRUd3a1ExSHVPUXJna0laeUJ4b3FhY2VyUDNBaVZ4QWdqSmNsRWZQZVBXTlFseG1ETUJaNEpibzc0MFpRTUhLZENoUFlLX1JBWEowdDRrMzlB?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-30/eli-lilly-says-closely-watched-combo-obesity-regimen-boosts-weight-loss-in-mid*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*